Compagnie Lombard Odier SCmA’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,000	Closed	-$94.9K	–	632
2023 Q3	$94.9K	Hold	3,000	–	–	﹤0.01%	362
2023 Q2	$122K	Buy	3,000 +1,500	+100%	+$61.2K	﹤0.01%	333
2023 Q1	$55.9K	Hold	1,500	–	–	﹤0.01%	433
2022 Q4	$52K	Hold	1,500	–	–	﹤0.01%	471
2022 Q3	$84K	Sell	1,500 -450	-23%	-$25.2K	﹤0.01%	413
2022 Q2	$101K	Hold	1,950	–	–	﹤0.01%	375
2022 Q1	$142K	Buy	1,950 +450	+30%	+$32.8K	﹤0.01%	345
2021 Q4	$177K	Hold	1,500	–	–	﹤0.01%	381
2021 Q3	$201K	Sell	1,500 -1,500	-50%	-$201K	﹤0.01%	355
2021 Q2	$486K	Sell	3,000 -282,520	-99%	-$45.8M	0.01%	228
2021 Q1	$22.9M	Buy	285,520 +279,520	+4,659%	+$22.4M	0.51%	43
2020 Q4	$326K	Sell	6,000 -4,000	-40%	-$217K	0.01%	275
2020 Q3	$199K	Hold	10,000	–	–	0.01%	274
2020 Q2	$210K	Hold	10,000	–	–	0.01%	257
2020 Q1	$122K	Hold	10,000	–	–	0.01%	276
2019 Q4	$147K	Buy	10,000 +2,000	+25%	+$29.4K	0.01%	275
2019 Q3	$107K	Hold	8,000	–	–	﹤0.01%	299
2019 Q2	$131K	Hold	8,000	–	–	0.01%	278
2019 Q1	$137K	Buy	8,000 +1,000	+14%	+$17.1K	0.01%	313
2018 Q4	$96K	Hold	7,000	–	–	﹤0.01%	328
2018 Q3	$200K	Hold	7,000	–	–	0.01%	292
2018 Q2	$192K	Hold	7,000	–	–	0.01%	286
2018 Q1	$148K	Sell	7,000 -7,000	-50%	-$148K	0.01%	334
2017 Q4	$270K	Buy	14,000 +7,000	+100%	+$135K	﹤0.01%	352
2017 Q3	$174K	Buy	7,000 +2,500	+56%	+$62.1K	0.01%	377
2017 Q2	$72K	Hold	4,500	–	–	﹤0.01%	467
2017 Q1	$63K	Buy	4,500 +1,500	+50%	+$21K	﹤0.01%	510
2016 Q4	$39K	Hold	3,000	–	–	﹤0.01%	638
2016 Q3	$51K	Hold	3,000	–	–	﹤0.01%	674
2016 Q2	$64K	Buy	+3,000	New	+$64K	﹤0.01%	628